Genetic Technologies Ltd. ADR (GENE) Social Stream
Genetic Technologies Ltd (GENE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Genetic Technologies Ltd.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 1 | $25.65 | $25.65 | $25.65 | $2.86 | 796.85% |
Price Target Last Issued November 30, 2016
GENE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GENE as an investment opportunity.
- The number of analysts covering the stock of GENE is higher than just about none of of all US stocks.
- The variance in analysts' estimates of GENE is less than almost 100% of all US stocks.
- The upside potential (average analyst target price relative to current price) of GENE is greater than 98.17% of all US stocks.
- Genetic Technologies Ltd's average analyst price target is greater than 84.82% of stocks in the micro market cap category.
Is GENE a Buy, Hold or Sell? See the POWR Ratings now!